Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease
K Fuxe, D Guidolin, LF Agnati… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Several types of D2R and D1R heteroreceptor complexes were discovered in
the indirect and direct pathways of the striatum, respectively. The hypothesis is given that …
the indirect and direct pathways of the striatum, respectively. The hypothesis is given that …
Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?
A Galvan, M Kuwajima, Y Smith - Neuroscience, 2006 - Elsevier
GABA and glutamate, the main transmitters in the basal ganglia, exert their effects through
ionotropic and metabotropic receptors. The dynamic activation of these receptors in …
ionotropic and metabotropic receptors. The dynamic activation of these receptors in …
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
The extracellular concentration of adenosine in the brain increases dramatically during
ischemia. Adenosine A2A receptor is expressed in neurons and glial cells and in …
ischemia. Adenosine A2A receptor is expressed in neurons and glial cells and in …
Joint-connectivity-based sparse canonical correlation analysis of imaging genetics for detecting biomarkers of Parkinson's disease
Imaging genetics is a method used to detect associations between imaging and genetic
variables. Some researchers have used sparse canonical correlation analysis (SCCA) for …
variables. Some researchers have used sparse canonical correlation analysis (SCCA) for …
Selective inactivation of adenosine A2A receptors in striatal neurons enhances working memory and reversal learning
The adenosine A2A receptor (A2AR) is highly enriched in the striatum where it is uniquely
positioned to integrate dopaminergic, glutamatergic, and other signals to modulate …
positioned to integrate dopaminergic, glutamatergic, and other signals to modulate …
[HTML][HTML] Allosteric Modulation of Adenosine A2A Receptors as a New Therapeutic Avenue
The therapeutic potential of targeting adenosine A2A receptors (A2ARs) is immense due to
their broad expression in the body and central nervous system. The role of A2ARs in …
their broad expression in the body and central nervous system. The role of A2ARs in …
Adenosine receptor‐mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N‐methyl‐d‐aspartate …
D Quarta, J Borycz, M Solinas, K Patkar… - Journal of …, 2004 - Wiley Online Library
Adenosine, by acting on adenosine A1 and A2A receptors, exerts opposite modulatory roles
on striatal extracellular levels of glutamate and dopamine, with activation of A1 inhibiting …
on striatal extracellular levels of glutamate and dopamine, with activation of A1 inhibiting …
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease
V Bagetta, B Picconi, S Marinucci… - Journal of …, 2011 - Soc Neuroscience
Striatal medium spiny neurons (MSNs) are divided into two subpopulations exerting distinct
effects on motor behavior. Transgenic mice carrying bacterial artificial chromosome (BAC) …
effects on motor behavior. Transgenic mice carrying bacterial artificial chromosome (BAC) …
Key Modulatory Role of Presynaptic Adenosine A2A Receptors in Cortical Neurotransmission to the Striatal Direct Pathway
C Quiroz, R Luján, M Uchigashima… - The Scientific World …, 2009 - Wiley Online Library
Basal ganglia processing results from a balanced activation of direct and indirect striatal
efferent pathways, which are controlled by dopamine D1 and D2 receptors, respectively …
efferent pathways, which are controlled by dopamine D1 and D2 receptors, respectively …
KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse
The risk of Parkinson's disease (PD) is associated with a lower intake of caffeine, a non-
selective adenosine A2A antagonist. In agreement, genetic or pharmacological inactivation …
selective adenosine A2A antagonist. In agreement, genetic or pharmacological inactivation …